Caisse De Depot Et Placement Du Quebec Nektar Therapeutics Transaction History

Caisse De Depot Et Placement Du Quebec

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$16.91 - $36.27 $130,207 - $279,279	-7,700 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$31.0 - $36.3 $238,700 - $279,510	7,700 New	7,700 $274,000
Q4 2018 Feb 14, 2019	SELL	$30.43 - $56.65 $1.93 Million - $3.59 Million	-63,400 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $2.95 Million - $4.34 Million	63,400 New	63,400 $3.87 Million

126

109M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $259M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.